Medibank share price slides following latest blows from hackers and customers

Medibank was hit by a major data breach on 12 October, exposing key details from some 9.7 million customers.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price is currently down 3.2% to $2.74.

The S&P/ASX 200 Index (ASX: XJO) health insurer is again making headlines today for the massive data breach it suffered on 12 October.

Cybercriminals managed to access the name, date of birth, address, phone number and email address of 9.7 million current and former customers. The hackers also accessed health claims data for some 480,000 customers.

Yesterday the Medibank share price closed higher after the company said it would not pay any ransom to the hackers.

A group of business people sit dejectedly around a table, each expressing desolation, sadness, and disappointment by holding their head in their hands, casting their gazes down and looking very glum.

Image source: Getty Images

Why is the Medibank share price under pressure today?

The renewed pressure on the Medibank share price looks to be coming from two fronts: its disgruntled customers and the hackers.

On the hacking front, the purportedly Russian hackers have threatened to publish the stolen data of all the customers unless their demands are met.

As The Australian reports, the hackers have urged people to sell their Medibank shares, while delivering this threat, "A man who has committed a mistake and doesn't correct it is committing another mistake. –Confucius… Data will be publish in 24 hours."

In separate headwinds for the Medibank share price, the health insurance giant is facing a class action suit, as The Motley Fool reported here earlier today.

Bannister Law Class Actions and Centennial Lawyers have stated that they will jointly investigate the cyber breach.

"The lawyers will also assess whether damages should be paid to Medibank customers as a result of their breaches," Bannister said.

How has Medibank been tracking?

The Medibank share price has yet to recover from the sharp sell-off the company faced following the hacking attack in October.

With today's intraday losses factored in, shares are down 20% year to date. For some context, the ASX 200 is down 8% in 2022.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

Why ResMed shares are tumbling 6% today despite strong results

Here's what spooked investors.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Imricor Medical Systems shares: Philips declares compatibility for iMR products

Big news is catching the eye of investors on Friday.

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Earnings Results

ResMed posts strong Q4 earnings, lifts dividend

The sleep disorder treatment company had another record quarter.

Read more »

a doctor wearing a white coat with a stethoscope around her neck stares out a window with her hand to the side of her face as though in deep thought.
Healthcare Shares

Clarity Pharmaceuticals reports clinical trial milestones

Clarity Pharmaceuticals reported continued clinical progress for its prostate cancer imaging and therapy programs.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Are Neuren Pharmaceuticals shares a buy, hold or sell after rocketing 16%?

This healthcare stock keeps rising.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Clarity Pharmaceuticals reports new SECuRE trial responses at higher dose

Clarity Pharmaceuticals reports further progress in its SECuRE prostate cancer trial, showing strong PSA responses and new complete responses at…

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Neuren Pharmaceuticals share price rockets: record Q2 DAYBUE sales and royalty upgrade

Second quarter net sales of DAYBUE increased 30%.

Read more »